Sentences with phrase «year dividend growth rate of»

Hasbro's dividend increase record is impressive: 15 straight years of increases; 5 - year dividend growth rate of 10.0 % per year; and an increase of 10.5 % this year.

Its 5 - year dividend growth rate of 24.7 % ranks higher than 85 % of its industry peers.

It's forward PE ratio is a little rich at 19, but the stock yields 2.74 % and has a 10 - year dividend growth rate of 4 %.

HCN is the largest healthcare REIT by market cap and sports an impressive 4.86 % dividend yield and a 5 - year dividend growth rate of 3.2 %.

Baxter has been growing the dividend for seven years now, with a 5 - year dividend growth rate of 16.4 %.

In addition, JNJ has increased their dividend for an incredible 52 consecutive years with a 5 year dividend growth rate of 7.3 %.

ITC yields just 1.7 %, but has a three - year dividend growth rate of 10 %.

On top of that, the company is a Dividend Champion having increased its dividend each of the past 29 years, with a ten - year dividend growth rate of 16.6 %.

Ventas is the second - largest healthcare REIT by market cap and sports an impressive 4.7 % dividend yield and a 5 - year dividend growth rate of 7.7 %.

It has a five year dividend growth rate of 8.36 percent, and a dividend payout ratio of roughly 49 percent.

• Apparent commitment to raising dividends, with a 14 - year streak of increases and a 5 - year dividend growth rate of about 17 % per year.

Since 2001, the largest increase in the quarterly dividend has been half a cent, resulting in a 5 - year dividend growth rate of 2.40 %.

with a 10 - year dividend growth rate of 12 %.

They've been paying out an increasing dividend for 20 consecutive years, with a 10 - year dividend growth rate of 9.8 %.

For the last 20 years, the company has increased the year - over-year quarterly dividend by no more than a penny, resulting in a 5 - year dividend growth rate of 2.68 %.

22 consecutive years of dividend raises, a 10 - year dividend growth rate of 12.8 %, and a recent dividend increase of 10 %.

EMR pays a dividend of 3.49 % and has a 3 - year dividend growth rate of 5.5 %, 5 - year dividend growth rate of 7.0 %, and a 10 - year dividend growth rate of 8.5 %.

The company has a seven - year dividend growth rate of 23.0 % and a seven - year earnings growth rate of 17.5 %.

I factored in a 10 % discount rate, a 10 - year dividend growth rate of 14 %, and a long - term dividend growth rate of 7.5 %.

• Corporate culture of raising dividends, with a 20 - year streak of increases and a 5 - year dividend growth rate of 15 % per year, all done while keeping the payout ratio low at 35 %.

The ADM dividend yield is a healthy 2.4 % but it is the 5 - year dividend growth rate of 11.4 % that makes it really attractive.

Hasbro's dividend increase record is impressive: 15 straight years of increases; 5 - year dividend growth rate of 10.0 % per year; and an increase of 10.5 % this year.

PEP currently sports a 2.88 % dividend yield and a 10 year dividend growth rate of 8.9 %.

LEG has paid dividends for 46 years straight and with a 10 year dividend growth rate of 7.2 % and dividend yield of 3.4 % it fit perfectly into my income & growth profile range of 3.5 % yield with min 6.7 % growth.

with a 10 - year dividend growth rate of 12 %.

They've been paying out an increasing dividend for 20 consecutive years, with a 10 - year dividend growth rate of 9.8 %.

We're talking 40 consecutive years of dividend increases here, a 10 - year dividend growth rate of 14.7 %, and an «almost - perfect» payout ratio of 50.5 %.

• 5 - year dividend growth rate of just under 20 % per year.

As of March, Southwest Airlines had a phenomenal three - year dividend growth rate of 101.2 percent, according to GuruFocus data.

These cutoffs are loosely based on the average 5 - year dividend growth rates of stocks on the CCC list with outliers removed.

Using the current years Dividend Growth rate of 2 % and projecting 2 % forward the annual dividend income in 10 yrs would be $ 0.00 with a yield on cost % of 3.00 %

Not exact matches

I am pleased to announce that our Board of Directors declared a 7 % increase in our quarterly cash dividend to $ 0.77 per share, marking 14 consecutive years of dividend increases with a compound annual growth rate of about 10 % over that period.

Given Osiris's strong five - year record of growth and profitability, Bowers was able to help make Miller's wishes come true: he structured a deal that raised $ 13 million from a large local pension fund — the Pennsylvania Public School Employees Retirement System (see «What Pension Funds Want,» [Article link]-RRB--- by selling a package of subordinated debt and convertible preferred stock, which included a fixed interest rate and dividend yield.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

The U.S. rate hike that the market is 100 percent certain will be delivered this week did not stop Dividend Equity Funds from recording their biggest inflow since the record setting $ 9.4 billion they took in exactly three years ago, with investors translating recent earnings per share growth and expected repatriation of foreign cash piles into bigger dividend Dividend Equity Funds from recording their biggest inflow since the record setting $ 9.4 billion they took in exactly three years ago, with investors translating recent earnings per share growth and expected repatriation of foreign cash piles into bigger dividend dividend payouts.

This growth rate is the compound annual growth rate of cash dividends per common share of stock over the last 5 years.

To me, the process is simple: If you are contemplating the purchase of a company with a high internal growth rate (which I define as expected growth north of 10 % for the next ten year years), and it pays no dividend or a negligible dividend, then stuff the investment in a taxable account provided you have already gotten any possible matching from a company's retirement account.

Simply Safe Dividends gives ALL of the criteria items I need in just one place in both numerical as well as graphical format for each stock: dividend yield, P / E ratio, Dividend Safety & Growth scores, EPS & FCF payout ratios, ex-dividend dates, pay dates, 1 -, 3 -, 5 -, and 10 - year dividend growth rates, dividend payout history, return on equity, adividend yield, P / E ratio, Dividend Safety & Growth scores, EPS & FCF payout ratios, ex-dividend dates, pay dates, 1 -, 3 -, 5 -, and 10 - year dividend growth rates, dividend payout history, return on equity, aDividend Safety & Growth scores, EPS & FCF payout ratios, ex-dividend dates, pay dates, 1 -, 3 -, 5 -, and 10 - year dividend growth rates, dividend payout history, return on equity, andGrowth scores, EPS & FCF payout ratios, ex-dividend dates, pay dates, 1 -, 3 -, 5 -, and 10 - year dividend growth rates, dividend payout history, return on equity, adividend dates, pay dates, 1 -, 3 -, 5 -, and 10 - year dividend growth rates, dividend payout history, return on equity, adividend growth rates, dividend payout history, return on equity, andgrowth rates, dividend payout history, return on equity, adividend payout history, return on equity, and more.

Given this, we expect the rate of dividend growth to moderate beyond this year, with increases likely tracking closely to earnings growth, which figures to average 8 % -10 % annually between 2018 and 2020.

It currently sports dividend growth rates of: 40.4 % for 1 year, 38.3 % for 3 year, and 45.9 % for its 5 year average.

This is a method of identifying candidates for purchase based on a combination of yield and (5 - year) dividend growth rate.

However, make sure to check their dividend growth rate of the last years so you have still an indicator that the dividends are growing.

This table shows the annual rate of LAZ's dividend growth since its current streak of 10 years started.

Where: D = Expected dividend per share one year from now k = Required rate of return for equity investor G = Growth rate in dividends (in perpetuity)

• The company's rate of dividend growth each year has been steadily high since the Great Recession ended in 2009.

In a fairly poor scenario, even if only a 5.7 % long - term EPS / dividend growth rate is achieved (chosen to match the previous 7 - year average EPS growth), then the current price in the low $ 80's can still offer a 9 % long - term rate of return, based on the DDM again.

• Stellar dividend resume: Decent yield at 2.9 %; excellent dividend growth rate of 20 % over the past 5 years; upcoming increase of 14 % in December; strong dividend safety, protected by very good cash flow; and 44 - year streak of increasing dividends.

While the company's five consecutive years of dividend increases is a bit shorter of a track record than I'd typically like to see, the dividend growth has been tremendous: the stock's three - year dividend growth rate is sitting at 44.2 %.

As I noted in the most recent Undervalued Dividend Growth Stock of the Week article on this stock, Enbridge grew its ACFFO at a compound annual rate of 7.94 % over the last ten fiscal years.

The current yield of 1.55 % might not be massive like AT&T's dividend (which is why we diversify, and it's why I'm listing 10 different stocks with different dynamics here), but Walt Disney more than makes up for that via strong dividend growth: the five - year dividend growth rate is 30.1 %, which is one of the higher rates you'll run across.